|
SKYE | Skye Bioscience, Inc. |
|
|
SKYE | Skye Bioscience, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.42 |
| Leverage | 7.03% |
| Market Cap | $ 53.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -21.4m |
| Margin | -15087.58% |